Member Info for Mafuta

https://twitter.com/Sareumplc/status/1534449808483688449?t=qTJIMATAycSyVQUusuGx3w&s=19

We are delighted to announce the appointment of Martin Gouldstone as an Independent Non-Executive Director with immediate effect.

Martin has 30 years of corporate development experience in the #CRO, #healthcare & #pharma sectors.

Learn more:

https://t.co/gLiAdsxpbf

#ORPH https://t.co/DkxG4pYYU7

Aren't thinking ... Everything is lining up but they are discussing semantics ... Its painfully slow but we will get there ... Patience Children and stop chanting "are we there yet?" ... LH&K Mafuta

Financial highlights

· Record revenues of £39.0m (2020: £22.2m) achieved representing 76% growth

· £9m improvement in EBITDA generating £2.9m (2020: £(6.1)m)

· Cash and cash equivalents as at 31 December 2021 of £15.7m (2020: £19.2m)

· Significant EPS improvement in 2021 to (0.01)p per share (2020: (1.80)p)

· Order book growth of 11% to £46m future contracted revenue as at 31 December 2021 (2020: £41.6m)

What's not to like

why SAR have not attended any seminars or presentations lately .... Have they been "advised" not to? ... LH &K Mafuta

Another chestnut gets pulled out of the fire ... Great news indeed.

If I felt a company was a dog or a scam I would get out and cut my losses ... I wouldn't stick around and consistently bad mouth the company or its employees ... I draw some confidence from the fact that some large holders are not selling out ... like Ralovatt my time frame has also extended somewhat ...rant on if that makes you feel better ... but I doubt it ... LH&K Mafuta

" ...the Contract Research Organisation ("CRO") undertaking the study had a protocol failure, voiding the study ... The CRO repeated the study as per the protocol ... the results, however, were inconsistent ... no positive or negative conclusions could be drawn from this study."

So the CRO stuffed up the first study and using the SAME PROTOCOL couldn't get conclusive results .... sounds like they need a different CRO in my opinion ... meanwhile Oxillo are waiting in the wings ... ho hum

Hmmm not the best of news ... Bit at least they are not having to pay a CEO ... ;0/

Dusty: "Sorry about spellings because I'm on the wine again" ... Could this perhaps be a major contribution towards your pecuniary embarrassment?

No problems from AJ Bell ... shares available on account and tradable ... LH&K Mafuta

I have seen the last couple of days as a good opportunity to average down ... which I did ... I will now sit on my hands and wait ... Without stating the obvious ... Pharma stock can test your patience ... LH&K Mafuta

Is this a smoke screen from Sierra?

https://twitter.com/sierraoncology/status/1529931188349157397?t=D8kgNw_sWO5xg9rDinJIJQ&s=19

And:
https://twitter.com/PoolbegPharma/status/1529706486036840448?t=Ulftg3HjKpAWkRPeUHtcbQ&s=19

Company comments: "The additional US patent protection of POLB 001 and POLB 002 is an important step in the commercialisation of these novel infectious disease products. Enhancing the IP protection of these assets across key markets such as the US increases the overall value of these products to potential partners, particularly as we move closer to the commencement of our POLB 001 LPS human challenge trial next month with data expected by year end and monetisation to commence thereafter."

What's not to like LH&K Mafuta

I find it incredible that the authorities cite falling infection numbers .... what do they expect LFTs aren't free anymore .... LH&K Mafuta

More like the poodle kept howling ... Woof woof woof

Woo Hoo the poodle is still posting ... Good news ... Accumulate at these levels if you have funds ... DYOR and don't bark too much

When the share bashers appear it can be a tad wearisome ... But at least their presence means someone is accumulating and is short of their target ... LH&K Mafuta

I wonder why this preoccupation with MCap? ... it's the projected value of the assets that will determine the offer (if any) ... the value of the pipeline for the duration of the patent period ... market volume and value of those products in the market over the same period ... but hey ho what do I know? ... LH&K Mafuta